Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PR Newswire
FDA Approves Blueprint Medicines’ AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
June 16, 2021 -
PR Newswire
Protenus Raises Series D After Doubling Revenue While Reducing Risk for Health Systems
June 15, 2021 -
PR Newswire
Innovent Announces First Overweight or Obese Subject Dosed in A Phase 2 Clinical Trial of IBI362 (a GLP-1 and Glucagon Receptor Dual Agonist) in China
June 15, 2021 -
Business Wire
Iora Health and Devoted Health Partner in Houston
June 14, 2021 -
Seeking Alpha
Verve Therapeutics Prepares $201 Million IPO
June 14, 2021 -
Business Wire
Equality Health Launches Partnership with Devoted Health
June 14, 2021 -
GlobeNewswire
GeneTx and Ultragenyx Receive Approval from U.K. Regulatory Agency to Begin Clinical Study of GTX-102 for the Treatment of Angelman Syndrome
June 10, 2021 -
One Medical
One Medical Announces Agreement to Acquire Iora Health
June 7, 2021 -
Forbes
Beam Therapeutics Cofounder And Crispr Scientist Publishes Research On New Sickle Cell Treatment In Mice
June 2, 2021 -
PR Newswire
Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology’s Medical Journal “Blood”
June 2, 2021 -
GlobeNewswire
Zenflow Announces $24 Million Financing Round; Appoints Susan Stimson as President
June 2, 2021 -
Business Wire
Verve Therapeutics Appoints Leading Biotechnology Executive Michael MacLean to its Board of Directors
June 1, 2021 -
PR Newswire
Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships
June 1, 2021 -
Business Wire
Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo
June 1, 2021 -
PR Newswire
Innovaccer Partners With PatientPing to Empower Physicians With Real-Time Care Coordination
June 1, 2021 -
GlobeNewswire
AnHeart Therapeutics and Innovent Biologics Announce Exclusive License Agreement for Taletrectinib in Greater China
May 31, 2021 -
Renaissance Capital Report
Gene editing biotech Verve Therapeutics files for a $100 million IPO
May 28, 2021 -
GlobeNewswire
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 -
PR Newswire
NFlection Therapeutics’ NFX-179 Gel Demonstrates Safety and Significant Reduction in p-ERK, a Key Biomarker Driving Neurofibroma Tumor Growth, in Positive Data From a 28-Day Phase 2a Clinical Trial
May 26, 2021 -
GlobeNewswire
Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock
May 26, 2021 -
GlobeNewswire
Apellis and Sobi Report Positive Top-line Results from the Phase 3 PRINCE Study of EMPAVELI™ (pegcetacoplan) in Treatment-naïve Patients with PNH
May 25, 2021 -
Business Wire
Xilio Therapeutics Announces Clinical Trial Collaboration With Merck on Anti-CTLA-4 Monoclonal Antibody Program
May 25, 2021 -
PR Newswire
Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma
May 24, 2021 -
Business Wire
Xilio Therapeutics to Present Preclinical Data Highlighting Anti-Tumor Activity and Tolerability of XTX202 at the 2021 ASCO Annual Meeting
May 20, 2021 -
GlobeNewswire
GeneTx and Ultragenyx Receive Clearance from Health Canada to Begin Clinical Study of GTX-102 in Canada for the Treatment of Angelman Syndrome
May 19, 2021 -
GlobeNewswire
Adagene Presents Clinical Data from NEObody™ Program, ADG106, Anti-CD137 Agonist, in an Abstract at ASCO 2021 Annual Meeting
May 19, 2021 -
FierceBiotech
ASCO: Adaptimmune’s cell therapy shrinks 39% of rare sarcomas
May 19, 2021 -
PR Newswire
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
May 18, 2021 -
PR Newswire
LunaPBC Announces Joe Beery as New Chief Executive Officer
May 18, 2021 -
PR Newswire
Protenus Selected as One of the Best Places to Work in Healthcare for Fourth Straight Year
May 17, 2021 -
Business Wire
Caribou Biosciences Announces Appointment of Katy Rezvani, M.D., Ph.D. and Christopher Sturgeon, Ph.D. to its Scientific Advisory Board
May 17, 2021 -
PR Newswire
Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2021 -
GlobeNewswire
Ultragenyx Announces Positive Multi-Year Durability Data from Ongoing Phase 1/2 Gene Therapy Studies and Data on HeLa 3.0 Manufacturing Platform at American Society of Gene & Cell Therapy 2021 Annual Meeting
May 14, 2021 -
GlobeNewswire
Apellis Announces U.S. Food and Drug Administration (FDA) Approval of EMPAVELI™ (pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
May 14, 2021 -
GlobeNewswire
Affinia Therapeutics Presents New Data and Updates on AAV Platform at American Society of Gene and Cell Therapy Annual Meeting
May 13, 2021 -
Business Wire
Xilio Therapeutics Presents Preclinical Tumor-Selective Activity and Tolerability Data for XTX101 at Frontiers in Cancer Immunotherapy Virtual Symposium
May 12, 2021 -
PR Newswire
Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)
May 12, 2021 -
GlobeNewswire
First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model
May 11, 2021 -
GlobeNewswire
Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID
May 11, 2021 -
GlobeNewswire
Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results
May 11, 2021 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Supply Agreement with Regeneron to Evaluate Vidutolimod (CMP-001) in Combination with Libtayo® (cemiplimab)
May 10, 2021 -
Renaissance Capital Report
Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO
May 7, 2021 -
Business Wire
Turnstone Biologics Announces Executive Leadership Promotions and Board Appointment
May 7, 2021 -
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 6, 2021 -
Business Wire
Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors
May 5, 2021 -
Business Wire
Verve Therapeutics Appoints Industry Leader Sheila Mikhail to its Board of Directors
May 5, 2021 -
Business Wire
Xilio Therapeutics Appoints Christina Rossi to Its Board of Directors
May 5, 2021 -
PR Newswire
Protenus’ 5th Annual PANDAS Conference Cultivates Innovation and Compliance Best Practices Throughout COVID-19 Pandemic
May 5, 2021 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma
May 4, 2021 -
PR Newswire
Centivo launches new health plan for self-funded employers in Iowa utilizing Incirca Health Network, powered by MercyOne
May 4, 2021 -
GlobeNewswire
Affinia Therapeutics Closes $110 Million Series B Financing
May 3, 2021 -
GlobeNewswire
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 1, 2021 -
PR Newswire
Carrot Fertility and Legacy Partner to Expand Access to Male Fertility Care
April 28, 2021 -
PR Newswire
Announcing 1upHealth’s $25 million Series B led by F-Prime
April 28, 2021 -
PR Newswire
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration
April 28, 2021 -
GlobeNewswire
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
April 27, 2021 -
Business Today
Dental software start-up CareStack raises $22.5 million to fund expansion
April 27, 2021 -
GlobeNewswire
Ultragenyx Completes Successful End-of-Phase 2 Meeting with FDA and Finalizes Phase 3 Study Design for DTX301 Ornithine Transcarbamylase (OTC) Gene Therapy Program
April 22, 2021 -
PR Newswire
Papaya Announces Tools for Best-in-Class Employee Experience
April 21, 2021 -
Sifted
Proximie raises $38m for augmented reality surgery
April 21, 2021 -
GlobeNewswire
Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing
April 20, 2021 -
PR Newswire
Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China
April 19, 2021 -
Forbes
This Startup Raised $25 Million To Liberate Your Healthcare Data In The Cloud
April 14, 2021 -
PR Newswire
Former Blackboard VP of Engineering to Join Protenus
April 13, 2021 -
PR Newswire
Benchling Appoints Krista Anderson-Copperman to Its Board of Directors
April 13, 2021 -
GlobeNewswire
Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021
April 13, 2021 -
Business Wire
Xilio Therapeutics Strengthens Management Team with R&D Leadership Appointments
April 12, 2021 -
PR Newswire
onehome Partners with Devoted Health to Bring Post-Acute Home-Based Care to Medicare Advantage Members in Arizona, Ohio and San Antonio, TX
April 12, 2021 -
Business Wire
Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of Directors
April 12, 2021 -
PR Newswire
Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021
April 12, 2021 -
PR Newswire
onehome Partners with Devoted Health to Bring Post-Acute Home-Based Care to Medicare Advantage Members in Arizona, Ohio and San Antonio, TX
April 12, 2021 -
GlobeNewswire
Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021
April 9, 2021 -
Business Wire
Firefly Health Closes $40M Series B Led by Andreessen Horowitz (a16z)
April 7, 2021 -
Business Wire
n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases
April 5, 2021 -
PR Newswire
Benchling Hires Richard Wong as CFO and Zach Powers as CISO
April 2, 2021 -
BioSpace
Caribou Biosciences is Armoring Cells to Fight Disease Through CRISPR
March 30, 2021 -
PR Newswire
ONTOZRY® (cenobamate) receives European Commission approval for the treatment of drug-resistant focal-onset seizures in adults
March 30, 2021 -
PR Web
Iora Health and Devoted Health Partner in Phoenix
March 29, 2021 -
Business Wire
Xilio Therapeutics Strengthens Leadership Team with the Addition of Two Executives
March 29, 2021 -
GlobeNewswire
Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital
March 25, 2021 -
Patient Ping
Clearlake Capital and Insight Partners-backed Appriss Health Acquires PatientPing to Deliver Comprehensive Care Coordination Solutions
March 23, 2021 -
Forbes
Virtual Reality Startup Raises $29 Million To Help With Chronic Pain
March 23, 2021 -
PR Newswire
Citrine Medicine Announces Receipt of Clinical Trial Waiver from the National Medical Products Administration (NMPA) in China for Narcolepsy Therapy Wakix® (pitolisant) and Partnership With Chinese Alliance for Rare Diseases (CARD)
March 22, 2021 -
Business Wire
WellAir Announces Appointment of Brad Niemann as Executive Vice President of Healthcare
March 18, 2021 -
YourStory
OZiva raises $12M Series B investment by Eight Road Ventures, F-Prime Capital, and Matrix Partners Read more at: https://yourstory.com/2021/03/funding-alert-oziva-raises-12-million-series-b-investment
March 17, 2021 -
GlobeNewswire
FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies
March 17, 2021 -
GlobeNewswire
Adagene Announces First Patients Dosed in Global Phase 1 Clinical Trial of ADG126, Lead SAFEbody™ Program
March 16, 2021 -
GlobeNewswire
Wellframe Announces Peer-Reviewed Research Highlighting the Positive Impact of Digital Care Management
March 15, 2021 -
Business Wire
Altasciences Conducts Preclinical Studies in Support of Verve Therapeutics’ Gene Editing Approach for Cardiovascular Disease
March 12, 2021 -
GlobeNewswire
Denali Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to ETV:IDS (DNL310) for the Treatment of Patients with Hunter Syndrome (MPS II)
March 11, 2021
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.